Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate nasal spray for irritant (non-allergic) rhinitis
2015-004888-37Phase 2
- Sponsor
- GSK
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in non-allergic rhinitis (NAR) comparing FFNS arm with Placebo arm (2 arms). Primary endpoint: Mean change in daily reflective total nasal symptom scores.
02
Drugs
fluticasone
03
Conditions
non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on 2015-004888-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004888-37.